相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Why has therapy development for dementia failed in the last two decades?
Serge Gauthier et al.
ALZHEIMERS & DEMENTIA (2016)
Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems
Mireia Herrando-Grabulosa et al.
PLOS ONE (2016)
Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease
Ibrahim Gonzalez-Marrero et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Angiotensin-Converting Enzyme Inhibitors and Amyotrophic Lateral Sclerosis Risk A Total Population-Based Case-Control Study
Feng-Cheng Lin et al.
JAMA NEUROLOGY (2015)
Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis
G. Yacila et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
Merit E. Cudkowicz et al.
LANCET NEUROLOGY (2014)
Fast Skeletal Muscle Troponin Activator tirasemtiv Increases Muscle Function and Performance in the B6SJL-SOD1G93A ALS Mouse Model
Darren T. Hwee et al.
PLOS ONE (2014)
Zebrafish models of human motor neuron diseases: Advantages and limitations
Patrick J. Babin et al.
PROGRESS IN NEUROBIOLOGY (2014)
Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons
Brian J. Wainger et al.
CELL REPORTS (2014)
Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis
Ethan A. Winkler et al.
ACTA NEUROPATHOLOGICA (2013)
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis
Emanuele D'Amico et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
Weihua Zhao et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
The innate and adaptive immunological aspects in neurodegenerative diseases
Maria C.O. Rodrigues et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature
A. Chio et al.
NEUROEPIDEMIOLOGY (2013)
Functional Characterisation of the Maturation of the Blood-Brain Barrier in Larval Zebrafish
Angeleen Fleming et al.
PLOS ONE (2013)
Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer's Disease
Dharmini C. Mehta et al.
PHARMACEUTICAL RESEARCH (2013)
Modifying effect of arterial hypertension on amyotrophic lateral sclerosis
Caroline Moreau et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
Impaired blood-brain/spinal cord barrier in ALS patients
Svitlana Garbuzova-Davis et al.
BRAIN RESEARCH (2012)
Immunological Aspects in Amyotrophic Lateral Sclerosis
Maria Carolina O. Rodrigues et al.
TRANSLATIONAL STROKE RESEARCH (2012)
Amyotrophic lateral sclerosis: A neurovascular disease
Svitlana Garbuzova-Davis et al.
BRAIN RESEARCH (2011)
The Role of Immune and Inflammatory Mechanisms in ALS
P. A. McCombe et al.
CURRENT MOLECULAR MEDICINE (2011)
Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice
A. Florence Keller et al.
EXPERIMENTAL NEUROLOGY (2011)
Disruption of Neurovascular Unit Prior to Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis
Kazunori Miyazaki et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
Fenofibric Acid Reduces Fibronectin and Collagen Type IV Overexpression in Human Retinal Pigment Epithelial Cells Grown in Conditions Mimicking the Diabetic Milieu: Functional Implications in Retinal Permeability
Kyle Trudeau et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Toward more efficient clinical trials for amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Natural history of upper motor neuron-dominant ALS
Gianni Soraru et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
A pilot trial of memantine and riluzole in ALS: Correlation to CSF biomarkers
Todd D. Levine et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis
Mamede De Carvalho et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Clinical Trials for Neuroprotection in ALS
G. Siciliano et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease
Tennore Ramesh et al.
DISEASE MODELS & MECHANISMS (2010)
Incidence of amyotrophic lateral sclerosis in Europe
Giancarlo Logroscino et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Inflammation in ALS and SMA: Sorting out the good from the evil
Dimitra Papadimitriou et al.
NEUROBIOLOGY OF DISEASE (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Gray matter perfusion correlates with disease severity in ALS
Randall R. Rule et al.
NEUROLOGY (2010)
Current and emerging treatments for amyotrophic lateral sclerosis
Zoccolella
Neuropsychiatric Disease and Treatment (2010)
Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis
Stacey A. Sakowski et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Current Hypotheses for the Underlying Biology of Amyotrophic Lateral Sclerosis
Jeffrey D. Rothstein
ANNALS OF NEUROLOGY (2009)
Impaired blood-brain and blood-spinal cord barriers in mutant SOM-linked ALS rat
Charles Nicaise et al.
BRAIN RESEARCH (2009)
Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS
Colin K. Franz et al.
NEUROBIOLOGY OF DISEASE (2009)
DECREASED mRNA EXPRESSION OF TIGHT JUNCTION PROTEINS IN LUMBAR SPINAL CORDS OF PATIENTS WITH ALS
J. S. Henkel et al.
NEUROLOGY (2009)
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
Fanchon Bourasset et al.
NEUROPHARMACOLOGY (2009)
Direct transport of VEGF from the nasal cavity to brain
Ji-Ping Yang et al.
NEUROSCIENCE LETTERS (2009)
Amyotrophic lateral sclerosis
Lokesh C. Wijesekera et al.
ORPHANET JOURNAL OF RARE DISEASES (2009)
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Caroline Vance et al.
SCIENCE (2009)
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
T. J. Kwiatkowski et al.
SCIENCE (2009)
Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
Albert C. Ludolph et al.
Therapeutic Advances in Neurological Disorders (2009)
Implications of blood-brain barrier disruption in ALS
Svitlana Garbuzova-Davis et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS
Jeffrey Rosenfeld et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Design, power, and interpretation of studies in the standard murine model of ALS
Sean Scott et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
TDP-43 mutation in familial amyotrophic lateral sclerosis
Akio Yokoseki et al.
ANNALS OF NEUROLOGY (2008)
Functional and developmental analysis of the blood-brain barrier in zebrafish
Jae-Yeon Jeong et al.
BRAIN RESEARCH BULLETIN (2008)
Strategic approaches to developing drug treatments for ALS
Andrea M. Vincent et al.
DRUG DISCOVERY TODAY (2008)
Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity
James C. Dodge et al.
MOLECULAR THERAPY (2008)
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration
Zhihui Zhong et al.
NATURE NEUROSCIENCE (2008)
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
E. J. Sorenson et al.
NEUROLOGY (2008)
ALS drug development: Reflections from the past and a way forward
Swati Aggarwal et al.
NEUROTHERAPEUTICS (2008)
Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS
Angelo C. Lepore et al.
BRAIN RESEARCH (2007)
Oral administration of memantine prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis
In-Soo Joo et al.
JOURNAL OF CLINICAL NEUROLOGY (2007)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS
Svitlana Garbuzova-Davis et al.
PLOS ONE (2007)
The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS
Maria Laura Messi et al.
EXPERIMENTAL NEUROLOGY (2007)
Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS
Svitlana Garbuzova-Davis et al.
BRAIN RESEARCH (2007)
Emerging disease-modifying therapies for the treatment of motor neuron diseasd/amyotropic lateral sclerosis
Richard S. Bedlack et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy
S. Zoccolella et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
How common are the common neurologic disorders?
D. Hirtz et al.
NEUROLOGY (2007)
Lost in translation: Treatment trials in the SOD1 mouse and in human ALS
Michael Benatar
NEUROBIOLOGY OF DISEASE (2007)
Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls
E. Bilic et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Trial of celecoxib in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
ANNALS OF NEUROLOGY (2006)
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
MJ Greenway et al.
NATURE GENETICS (2006)
Astrocyte-endothelial interactions at the blood-brain barrier
NJ Abbott et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Piera Pasinelli et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model
RG Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis
I Nagano et al.
NEUROLOGICAL RESEARCH (2005)
An epidemiological study of motor neuron disease in Hong Kong
GCY Fong et al.
AMYOTROPHIC LATERAL SCLEROSIS (2005)
Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis
I Nagano et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
The pathobiology of amyotrophic lateral sclerosis: A proteinopathy?
MJ Strong et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Ramipril prevents extracellular matrix accumulation in cerebral microvessels
M Liebetrau et al.
NEUROLOGICAL RESEARCH (2005)
Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF
M Beck et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2005)
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
JD Rothstein et al.
NATURE (2005)
The blood-brain barrier: an overview - Structure, regulation, and clinical implications
P Ballabh et al.
NEUROBIOLOGY OF DISEASE (2004)
Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS
T Pirttilä et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000
BJ Traynor et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model
BK Kaspar et al.
SCIENCE (2003)
Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view
AW Vorbrodt et al.
BRAIN RESEARCH REVIEWS (2003)
Glial cell line-derived neurotrophic factor does not enter normal mouse brain
AJ Kastin et al.
NEUROSCIENCE LETTERS (2003)
A randomized sequential trial of creatine in amyotrophic lateral sclerosis
GJ Groeneveld et al.
ANNALS OF NEUROLOGY (2003)
Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS
WH Zhang et al.
ANNALS OF NEUROLOGY (2003)
Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS
DB Drachman et al.
ANNALS OF NEUROLOGY (2002)
Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis
J Kriz et al.
NEUROBIOLOGY OF DISEASE (2002)
Minocycline delays disease onset and mortality in a transgenic model of ALS
L Van Den Bosch et al.
NEUROREPORT (2002)
Astrocyte-endothelial interactions and blood-brain barrier permeability
NJ Abbott
JOURNAL OF ANATOMY (2002)
Glial cell influence on the human blood-brain barrier
A Prat et al.
GLIA (2001)
分享论文
